HealthStream director proposes $420K share sale

The listed acquisition entries describe HealthStream stock awards, including awards dated June 6, 2025 and April 26, 2016.

Rhea-AI Filing Summary

HealthStream, Inc. (HSTM) director Linda Rebrovick reports a proposed sale of 12,000 common shares, with an aggregate market value of $420,000. UBS Financial Services, Inc. is listed as broker; the approximate sale date is October 23, 2026, on Nasdaq. The listed share lots are described as stock awards from HealthStream.

Key Figures

Proposed sale: 12,000 common shares Aggregate market value: $420,000 Shares in stock-award lot: 2,132 shares

3 metrics

Proposed sale 12,000 common shares Approximate sale date: October 23, 2026

Aggregate market value $420,000 Proposed sale

Shares in stock-award lot 2,132 shares Award dated June 6, 2025

Key Terms

Rule 144, aggregate market value, attorney-in-fact

3 terms

Rule 144 regulatory

"paragraph (a) of Rule 144"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

aggregate market value financial

"Aggregate market value"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

attorney-in-fact regulatory

"as attorney-in-fact for Linda Rebrovick"

An attorney-in-fact is the person or entity given legal authority through a power of attorney to act on behalf of another for specific tasks, such as signing documents, voting shares, or handling transactions. For investors, this matters because it lets a trusted representative make timely decisions or complete paperwork when the owner cannot, much like handing keys to someone to run errands on your behalf—so checks on scope and limits of that authority are important.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many HSTM shares is Linda Rebrovick proposing to sell?

Linda Rebrovick's proposed sale covers 12,000 common shares, with an aggregate market value of $420,000. UBS Financial Services, Inc. is listed as broker, and the approximate sale date is October 23, 2026, on Nasdaq.

How did Linda Rebrovick acquire the HSTM shares?

The listed common-share lots are attributed to stock awards from HealthStream. Entries include awards dated June 6, 2025 and April 26, 2016.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/23/2026 - 04:13 PM EDT Accepted by SEC EDGAR 10/23/2026 - 04:13 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001217283
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	HEALTHSTREAM INC
SEC File Number	000-27701
Address of Issuer	500 11TH AVENUE NORTH SUITE 850 NASHVILLE TENNESSEE 37203
Phone	6153013100
Name of Person for Whose Account the Securities are To Be Sold	REBROVICK LINDA
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	UBS Financial Services, Inc. Eleven Madison Avenue 4th Floor New York NY 10010	12000	420000.00	29239955	10/23/2026	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	06/06/2025	Stock Award	Issuer			2132	06/06/2025	NA
Common	04/26/2016	Stock Award	Issuer			3337	04/26/2016	N/A
Common	06/06/2024	Stock Award	Issuer			1125	06/06/2024	N/A
Common	03/15/2019	Stock Award	Issuer			2874	03/15/2019	N/A
Common	06/10/2021	Stock Award	Issuer			401	06/10/2021	N/A
Common	03/25/2024	Stock Award	Issuer			2092	03/25/2024	N/A
Common	03/23/2023	Stock Award	Issuer			39	03/23/2023	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	10/23/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	11/21/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ UBS Financial Services Inc, as attorney-in-fact for Linda Rebrovick
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)